Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Illinois Wellness Insider.
Press releases published on June 19, 2025

Verano Announces Exclusive Partnership with Award-Winning Arizona Cannabis Operator Grow Sciences to Bring its Best-In-Class Products to Illinois
Grow Sciences flower, pre-rolls, solventless extracts, vaporizers and edibles will initially be sold exclusively at Zen Leaf dispensaries in the Illinois market CHICAGO, June 19, 2025 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) …

Symbiotic.blue Launches to Combine Oxford and Cambridge Scientific Brain Power with Bioentrepreneurial Leadership to Reinvent AI Drug Discovery
LONDON, June 19, 2025 (GLOBE NEWSWIRE) -- Symbiotic.blue, the UK’s newest Techbio company has launched to innovate a next-generation artificial intelligence-driven drug discovery (AIDD) platform by combining the power of generative AI with brain-inspired …

Mega Sardines Named World’s First Seafood “Superfood” by MWA
MANILA, Philippines, June 19, 2025 (GLOBE NEWSWIRE) -- Mega Sardines, a flagship brand of Mega Prime Foods Inc., has officially been recognized by the U.S.-based Medical Wellness Association (MWA) as the world’s first seafood Superfood, marking a historic …

CancerVax Nanoparticle Successfully Targets Cancer Cells While Sparing Non-cancerous Cells
Lehi, June 19, 2025 (GLOBE NEWSWIRE) -- Lehi, Utah – June 19, 2025 – CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform designed to use the body’s immune system to treat cancer, today announced that its ligand conjugated …

HLTH Inc. Unveils HLTH.rad — A Bold New Global Gathering for Imaging Innovators Co-Located with HLTH Europe 2026 in Amsterdam
AMSTERDAM, Netherlands, June 19, 2025 (GLOBE NEWSWIRE) -- HLTH Inc., the leading global platform for health innovation, is proud to announce the launch of HLTH.rad, a groundbreaking new event that will redefine the future of medical imaging, diagnostics, …

Addex Therapeutics Reports Q1 2025 Financial Results and Provides Corporate Update
Strong cash position of CHF2.8 million at end of Q1 2025 GABAB PAM chronic cough candidate demonstrated robust anti-tussive activity in disease models Regained rights to our phase 2 mGlu2 PAM asset, ADX71149 Indivior advanced GABAB PAM Substance use …